Exact Mass: 615.1862

Exact Mass Matches: 615.1862

Found 34 metabolites which its exact mass value is equals to given mass value 615.1862, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cep-1347

methyl 10,23-bis[(ethylsulfanyl)methyl]-16-hydroxy-15-methyl-3-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1^{15,18}.0^{2,6}.0^{7,27}.0^{8,13}.0^{19,26}.0^{20,25}]octacosa-1,6,8(13),9,11,20(25),21,23,26-nonaene-16-carboxylate

C33H33N3O5S2 (615.1862)

CXCR3 Antagonist 6c

4-[2-(3-chlorobenzamido)-4-{[2-(2,4-dichlorophenyl)ethyl]carbamoyl}phenyl]-N-ethyl-1,4-diazepane-1-carboxamide

C30H32Cl3N5O3 (615.1571)

Idasanutlin

4-[[3-(3-Chloro-2-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-5-(2,2-dimethylpropyl)pyrrolidine-2-carbonyl]amino]-3-methoxybenzoic acid

C31H29Cl2F2N3O4 (615.1503)

(+/-)-8-(p-hydroxybenzyl)-2,3,10,11-tetrahydroxyprotoberberine pentaacetate|8-(p-hydroxybenzyl)-2,3,10,11-tetrahydroxyprotoberberine penta-O-acetate

C34H33NO10 (615.2104)

MCDFT

Met-Cys-Asp-Phe-Thr

C25H37N5O9S2 (615.2033)

Fmoc-Cys(MMt)-OH

C38H33NO5S (615.2079)

AG-L-59687

C24H34BrN5O7S (615.1362)

Idasanutlin

C31H29Cl2F2N3O4 (615.1503)

C274 - Antineoplastic Agent > C129839 - Apoptotic Pathway-targeting Antineoplastic Agent > C162996 - MDM2 Inhibitor Idasanutlin (RG7388) is a potent and selective MDM2 antagonist, inhibiting p53-MDM2 binding, with an IC50 of 6 nM.

(5R-(5alpha,5abeta,8aalpha,9beta))-9-((2-Deoxy-2-(dimethylamino)-4,6-O-ethylidene-β-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3,4:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one

(5R-(5alpha,5abeta,8aalpha,9beta))-9-((2-Deoxy-2-(dimethylamino)-4,6-O-ethylidene-β-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3,4:6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one

C31H37NO12 (615.2316)

1,3,5-tris-(Trimethoxysilylpropyl)-isocyanurate

C21H45N3O12Si3 (615.2311)

Butamben picrate

C28H33N5O11 (615.2176)

D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

Methyl 2,11-bis[(ethylsulfanyl)methyl]-15-hydroxy-8-methyl-5,6,7,8-tetrahydro-13H-5,8-epoxy-4b,8a,14-triazadibenzo[b,h]cycloocta[1,2,3,4-jkl]cyclopenta[e]-as-indacene-7-carboperoxoate

C33H33N3O5S2 (615.1862)

N-[3-(4-{[1-(5-chloro-2,4-dimethoxyanilino)-1-oxopropan-2-yl]sulfanyl}anilino)-3-oxo-1-phenylprop-1-en-2-yl]benzamide

C33H30ClN3O5S (615.1595)

N-[(5S,6S,9R)-8-[1,3-benzodioxol-5-yl(oxo)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2,2,2-trifluoroethanesulfonamide

C27H32F3N3O8S (615.1862)

N-[(5S,6R,9R)-8-[1,3-benzodioxol-5-yl(oxo)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2,2,2-trifluoroethanesulfonamide

C27H32F3N3O8S (615.1862)

N-[(2R,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-chlorobenzenesulfonamide

C30H34ClN3O7S (615.1806)

N-[(4R,7R,8S)-5-(benzenesulfonyl)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methylbenzenesulfonamide

C30H37N3O7S2 (615.2073)

N-[(5R,6R,9S)-8-[1,3-benzodioxol-5-yl(oxo)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2,2,2-trifluoroethanesulfonamide

C27H32F3N3O8S (615.1862)

N-[(5R,6S,9S)-8-[1,3-benzodioxol-5-yl(oxo)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2,2,2-trifluoroethanesulfonamide

C27H32F3N3O8S (615.1862)

N-[(5S,6R,9S)-8-[1,3-benzodioxol-5-yl(oxo)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2,2,2-trifluoroethanesulfonamide

C27H32F3N3O8S (615.1862)

N-[(5R,6S,9R)-8-[1,3-benzodioxol-5-yl(oxo)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2,2,2-trifluoroethanesulfonamide

C27H32F3N3O8S (615.1862)

4-{[2,3,10,11-tetrakis(acetyloxy)-7,8,12b,13-tetrahydro-5h-6-azatetraphen-5-yl]methyl}phenyl acetate

C34H33NO10 (615.2104)

3-(3,4-dibromo-5-hydroxyphenyl)-3-hydroxy-1-octadecanoylpyrrolidin-2-one

C28H43Br2NO4 (615.1559)

12-[4-(acetyloxy)-3-methoxyphenyl]-8,16,17,18-tetramethoxy-4-oxa-1-azapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-2(11),5,7,9,12,14,16,18-octaen-7-yl acetate

C34H33NO10 (615.2104)

12-[4-(acetyloxy)-3-methoxyphenyl]-18-hydroxy-8,16,17-trimethoxy-3-oxo-4-oxa-1-azapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-2(11),5(10),6,8,12,14(19),15,17-octaen-7-yl acetate

C33H29NO11 (615.1741)

4-{[(5s,12br)-2,3,10,11-tetrakis(acetyloxy)-7,8,12b,13-tetrahydro-5h-6-azatetraphen-5-yl]methyl}phenyl acetate

C34H33NO10 (615.2104)

(3s)-3-(3,4-dibromo-5-hydroxyphenyl)-3-hydroxy-1-octadecanoylpyrrolidin-2-one

C28H43Br2NO4 (615.1559)

2-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}-5-[({[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}methanimidoyl)amino]-n-{[(1-hydroxy-2-oxopiperidin-3-yl)-c-hydroxycarbonimidoyl]methyl}pentanimidic acid

2-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}-5-[({[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}methanimidoyl)amino]-n-{[(1-hydroxy-2-oxopiperidin-3-yl)-c-hydroxycarbonimidoyl]methyl}pentanimidic acid

C27H33N7O10 (615.2289)

(2r)-2-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}-5-[({[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}methanimidoyl)amino]-n-({[(3s)-1-hydroxy-2-oxopiperidin-3-yl]-c-hydroxycarbonimidoyl}methyl)pentanimidic acid

(2r)-2-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}-5-[({[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}methanimidoyl)amino]-n-({[(3s)-1-hydroxy-2-oxopiperidin-3-yl]-c-hydroxycarbonimidoyl}methyl)pentanimidic acid

C27H33N7O10 (615.2289)